Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
Terminated
- Conditions
- Patent Ductus Arteriosus
- Registration Number
- NCT03026192
- Lead Sponsor
- Albany Medical College
- Brief Summary
Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
- preterm infants less than 32 weeks gestation
Exclusion Criteria
- infection, congenital heart disease, syndromic anomalies, and perinatal asphyxia.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in NIRS readings 3 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Albany Medical Center Neonatal Intesive Care Unit
🇺🇸Albany, New York, United States
Albany Medical Center Neonatal Intesive Care Unit🇺🇸Albany, New York, United States